Royal UNIBREW A/S
Share buy-back program
Share buy-back program
COMPANY ANNOUNCEMENT NO 27/2025 - May 19, 2025
On February 25, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 3/2025 of February 25, 2025.
The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016.
The share buy-back program is expected to be realized in the period from February 26, 2025, to August 15, 2025. The total transaction value of the share buy-backs in the period will not exceed DKK 250m.
The following transactions on Nasdaq Copenhagen A/S have been made under the program:
| Number of Shares | Average purchase price DKK | Transaction value, DKK | |
| Accumulated, last announcement | 188,727 | 545.65 | 102,979,152 |
| May 12, 2025 | 3,000 | 530,36 | 1,591,078 |
| May 13, 2025 | 5,000 | 522,22 | 2,611,098 |
| May 14, 2025 | 20,000 | 514,13 | 10,282,538 |
| May 15, 2025 | 4,240 | 520,30 | 2,206,076 |
| May 16, 2025 | 3,000 | 531,04 | 1,593,125 |
| Total accumulated under the program | 223,967 | 541.43 | 121,263,067 |
With the transactions stated above Royal Unibrew owns a total of 357,289 shares, corresponding to 0.7% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.
For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail: Flemming.Nielsen@royalunibrew.com
Telephone: +45 25 41 68 04
Encl.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sparekassen Sjælland-Fyn A/S19.5.2025 20:57:39 CEST | Pressemeddelelse
Bestyrelsen for Sparekassen Sjælland-Fyn A/S
Boehringer Ingelheim Limited19.5.2025 18:15:44 CEST | Press release
Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo
Syensqo SA19.5.2025 17:45:00 CEST | Press release
Syensqo - Acquisition of own shares
BTR New Material Group19.5.2025 17:10:27 CEST | Press release
BTR Unveils Breakthrough Solid-State Battery Solutions and Closed-Loop Recycling at CIBF2025
Yacht Club de Monaco19.5.2025 17:07:13 CEST | Press release
Monaco: Spring Pop-Up at the Yacht Club, United Towards Sustainable Transition
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom